Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Guardant Health

Colon Cancer Screening Leader Guardant Health Tests Buy Point As Earnings Loom

Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon cancer.

Investors Business Daily

Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 31% In A Month

Guardant Health stock broke out of a cup base as enthusiasm builds for the company's new blood test, Shield MCD.

Investors Business Daily

S&P 500's Walmart In Buy Zone, Leads Five Stocks Near Buy Points

S&P 500 giant Walmart and a profitable biotech are actionable, leading five stocks to watch amid a tricky market environment.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Erase Losses As Banks Rebound. Oracle, Interactive Brokers Slide.

Dow Jones futures turned higher as regional banks tried to bounce. Interactive Brokers and Oracle declined on news.

Investors Business Daily

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Guardant Health stock took a tumble Thursday after the company's second-generation colon cancer test lagged expectations in a pivotal study.

Investors Business Daily

Stocks Showing Market Leadership: Guardant Health Earns 92 RS Rating

Guardant Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Stocks To Watch: Guardant Health Sees Relative Strength Rating Jump To 85

Guardant Health sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Medical Services Name Flirts With A Buy Point

This medical services stock is in a cup-with-handle base. The biotech's tests detect cancer through blood tests.

Investors Business Daily

Dow Jones Futures Rise As Trump Buys Time For Iran; Tesla Robotaxi To Have Safety Monitor

President Trump gave himself "two weeks" for an Iran decision. Tesla sent out robotaxi invites, with some key details..

Investors Business Daily

Guardant Health Joins Rank Of Stocks With RS Ratings Over 90

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

Investors Business Daily

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

MarketBeat

Simple blood tests could be the future of cancer diagnosis

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

LiveScience

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

Exact Sciences stock crumbled Thursday on its growing rivalry with Guardant Health and Natera in colon cancer screening.

Investors Business Daily

Guardant Health Shows Market Leadership With Jump To 92 RS Rating

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

Guardant Health Stock Sees RS Rating Jump To 83

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

MarketBeat

Deciphering Disruption: Inside Cathie Wood's Latest Plays

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stocks Showing Improving Market Leadership: Guardant Health Earns 82 RS Rating

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop

Guardant Health stock jumped Thursday on an "impressive" third-quarter report following the launch of its cancer detection test, Shield.

Investors Business Daily

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat

Exact Sciences stock bounded higher Thursday after beating second-quarter expectations, signaling a return to growth for Cologuard.

Investors Business Daily

Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.

Investors Business Daily

Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales

Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.

WEKU

A simple blood test can detect colorectal cancer early, study finds

At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection.